HEPATOCHIP for diagnosis of non-alcoholic steatohepatitis, Owl Genomics

OWL Genomics, biotechnological company, has presented at the CIC bioGUNE hold at the Bizkaia Technological Park (Derio), the first DNA chip concerning diagnosis and prognosis of non-alcoholic steatohepatitis (NASH), allowing the discrimination between normal, steatosis and NASH predisposed subjects... click link for more info.

Continue to HEPATOCHIP for diagnosis of non-alcoholic steatohepatitis, Owl Genomics on Medical News Today.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz